Kings Point Capital Management’s Amgen AMGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q1
$495K Sell
2,047
-86
-4% -$19.8K 0.04% 134
2021
Q4
$480K Buy
2,133
+86
+4% +$18.2K 0.04% 149
2021
Q3
$435K Hold
2,047
0.04% 146
2021
Q2
$499K Hold
2,047
0.05% 139
2021
Q1
$509K Sell
2,047
-146
-7% -$34.8K 0.05% 136
2020
Q4
$504K Sell
2,193
-551
-20% -$127K 0.05% 130
2020
Q3
$697K Buy
2,744
+499
+22% +$124K 0.09% 114
2020
Q2
$529K Hold
2,245
0.08% 116
2020
Q1
$455K Buy
2,245
+100
+5% +$21.8K 0.08% 115
2019
Q4
$517K Buy
2,145
+624
+41% +$138K 0.08% 124
2019
Q3
$294K Buy
1,521
+230
+18% +$44.1K 0.05% 150
2019
Q2
$238K Buy
1,291
+46
+4% +$8.24K 0.04% 138
2019
Q1
$237K Sell
1,245
-26,249
-95% -$5.01M 0.05% 129
2018
Q4
$5.35M Buy
27,494
+5,083
+23% +$992K 1.19% 35
2018
Q3
$4.65M Buy
22,411
+1,408
+7% +$277K 0.87% 48
2018
Q2
$3.88M Buy
21,003
+1,129
+6% +$200K 0.76% 51
2018
Q1
$3.39M Buy
19,874
+2,237
+13% +$411K 0.68% 54
2017
Q4
$3.07M Buy
17,637
+1,653
+10% +$293K 0.64% 58
2017
Q3
$2.98M Buy
15,984
+2,226
+16% +$394K 0.66% 58
2017
Q2
$2.37M Buy
13,758
+1,611
+13% +$262K 0.55% 62
2017
Q1
$1.99M Buy
+12,147
New +$2.02M 0.47% 63
2014
Q3
Sell
-250
Closed -$30K 315
2014
Q2
$30K Buy
+250
New +$28.9K 0.01% 222

Other funds holding AMGN

Kings Point Capital Management's AMGN Position: Q1 2022 in Review

Kings Point Capital Management reduced its Amgen (AMGN) stake by 4% in Q1 2022, selling an estimated $19.8K and leaving 2,047 shares worth $495K. The position accounts for 0.04% of the portfolio, ranked #134.

Kings Point Capital Management first reported a position in AMGN in Q2 2014 and has held it in 22 quarters since. The position peaked at $5.35M in Q4 2018. 2,337 funds tracked by Wall St. Rank hold AMGN as of Q1 2022.

  • Kings Point Capital Management held 2,047 shares of Amgen worth $495K as of Q1 2022.
  • Kings Point Capital Management sold 86 Amgen shares in Q1 2022, an estimated $19.8K.
  • Amgen made up 0.04% of Kings Point Capital Management's portfolio in Q1 2022, its #134 holding.
  • Kings Point Capital Management first reported a position in Amgen in Q2 2014 and has held it in 22 quarters since.
  • Kings Point Capital Management's Amgen position peaked at $5.35M in Q4 2018.
  • 2,337 funds tracked by Wall St. Rank held Amgen as of Q1 2022.

Based on Kings Point Capital Management's 13F filing for Q1 2022, filed 13 May 2022.